Recherche
-
DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus
(Drug Safety. vol. 43, n° 8, pp. 767-774, 2020)Article de revue -
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective
(Cancers. vol. 13, n° 23, 2021-12-05)Article de revueLibre accès -
High prevalence of spin was found in pharmacovigilance studies usingdisproportionality analyses todetectsafetysignals: a meta-epidemiologicalstudy: Spin in pharmacovigilance disproportionality analyses
(Journal of Clinical Epidemiology. vol. 138, pp. 73-79, 2021-06-26)Article de revue -
Antipsychotics and risk of QT prolongation: a pharmacovigilance study
(Psychopharmacology. vol. 240, pp. 199-202, 2022-12-14)Article de revue -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
(Thérapie, 2021-04-02)Article de revue -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueLibre accès -
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines
(Drug Safety. vol. 43, n° 11, pp. 1089-1104, 2020)Article de revueLibre accès -
Medicine misuse: A systematic review and proposed hierarchical terminology
(British Journal of Clinical Pharmacology, 2020-12-08)Article de revue -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
Risk of bradyarrhythmia related to ticagrelor: a systematic review and meta-analysis
(Pharmacological Research. pp. 105089, 2020)Article de revue